Clinical trial
Effect of Early Administration of Albumin 20% Versus Crystalloid During Resuscitation of Patient With Septic Shock: a Randomized Controlled Trial
NCT06370078 is registered in ClinicalTrials.gov with Egymedicalpedia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Early Administration of Albumin 20% Versus Crystalloid During Resuscitation of Patient With Septic Shock: a Randomized Controlled Trial
- Lead sponsor
- Egymedicalpedia
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2024
- Completion date
- November 30, 2024
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock